Suchergebnisse - "Bouattour, Mohamed"

PubPharm (7)

1

Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH) : an open-label randomised controlled phase 3 trial

enthalten in: The Lancet. Oncology | 2017

von Vilgrain, V. | Pereira, H. | Assenat, E. | +135

CommentIn: Lancet Oncol. 2017 Dec;18(12):1560-1561. - PMID 29107680

2

Adjuvant therapies in advanced hepatocellular carcinoma : moving forward from the STORM

enthalten in: Trials | 2016

von Bouattour, M. | Soubrane, O. | de Gramont, A. | +1

3

Negative Trials for Foreseeable Safety Reasons in Advanced Hepatocellular Carcinoma : How Long Are We Going to Take Lightly Pharmacokinetics of Tyrosine Kinase Inhibitors?

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2015

von Bouattour, M. | Rousseau, B. | Wassermann, J. | +2

CommentOn: J Clin Oncol. 2015 Jan 10;33(2):172-9. - PMID 25488963

4

Alternative Response Criteria (Choi, European association for the study of the liver, and modified Response Evaluation Criteria in Solid Tumors [RECIST]) Versus RECIST 1.1 in patients with advanced hepatocellular carcinoma treated with sorafenib

enthalten in: The oncologist | 2014

von Ronot, M. | Bouattour, M. | Wassermann, J. | +8

5

Novel molecular therapies in hepatocellular carcinoma

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2011

von Faivre, S. | Bouattour, M. | Raymond, E.

6

Tolerance and outcome of patients with unresectable hepatocellular carcinoma treated with sorafenib

enthalten in: European journal of gastroenterology & hepatology | 2010

von Ozenne, V. | Paradis, V. | Pernot, S. | +6

7

Targeted therapies in hepatocellular carcinoma

enthalten in: Presse medicale (Paris, France : 1983) | 2010

von Bouattour, M. | Marijon, H. | Dreyer, C. | +2

1
[1]